CPIX
CUMBERLAND PHARMACEUTICALS INCCompany Information
- Company Name
- CUMBERLAND PHARMACEUTICALS INC
- CIK
- CIK0001087294
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CPIX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CPIX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-29
- Last sale
- —
- Shares purchased (TTM)
- 1,977
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,468,368
- Shares outstanding
- 14,981,607
- Ownership
- 16.48%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- 8.46%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 11 | 11 | 15 | 16 | 15 | 18 | 17 | 17 | 19 | 18 | 19 | ||||||
| Accounts Receivable Net Current | 13 | 14 | 17 | 10 | 10 | 10 | 12 | 11 | 12 | 11 | 10 | 13 | ||||||
| Inventory Net | 0 | 5 | 6 | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 5 | 9 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | 16 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 34 | 33 | 37 | 30 | 31 | 32 | 36 | 35 | 36 | 36 | 36 | 42 | ||||||
| Inventory Noncurrent | 0 | 10 | 9 | 9 | 10 | 10 | 11 | 12 | 12 | 13 | 13 | 8 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 22 | 23 | 27 | ||||||
| Goodwill | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 7 | 8 | 8 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 7 | 7 | ||||||
| Investments | - | 4 | 4 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Assets Of Disposal Group Including Discontinued Operation | 18 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 63 | 71 | 77 | 66 | 68 | 70 | 76 | 77 | 79 | 82 | 82 | 88 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 20 | 17 | 19 | 14 | 13 | 14 | 14 | 12 | 13 | 13 | 14 | 11 | ||||||
| Operating Lease Liability Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Lines Of Credit Current | - | - | - | 0 | 0 | 0 | - | 6 | - | - | - | - | ||||||
| Long Term Debt Current | - | - | 0 | - | - | - | 5 | - | - | - | 0 | - | ||||||
| Investment Related Liabilities | - | 4 | 5 | - | - | - | 0 | - | - | - | - | - | ||||||
| Accrued Liabilities Current | 8 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 2 | 13 | 13 | 10 | 10 | 11 | 12 | 13 | 12 | 13 | 14 | 16 | ||||||
| Disposal Group Including Discontinued Operation Accrued Liabilities Current | 5 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 35 | 34 | 37 | 24 | 24 | 26 | 32 | 31 | 25 | 26 | 28 | 27 | ||||||
| Long Term Line Of Credit | 0 | 5 | 5 | 5 | 5 | 5 | 10 | 10 | 16 | 16 | 13 | 13 | ||||||
| Operating Lease Liability Noncurrent | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Other Liabilities Noncurrent | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 6 | 6 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | 2 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 46 | 50 | 52 | 40 | 40 | 42 | 53 | 52 | 52 | 54 | 53 | 52 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Common Stock Value | - | - | - | - | - | - | - | - | - | - | - | 47 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value Outstanding | 52 | 52 | 52 | 52 | 51 | 51 | 47 | 47 | 47 | 47 | 47 | - | ||||||
| Retained Earnings Accumulated Deficit | -34 | -30 | -27 | -25 | -23 | -23 | -24 | -22 | -21 | -19 | -17 | -11 | ||||||
| Stockholders Equity | 17 | 22 | 25 | 26 | 28 | 29 | 23 | 24 | 26 | 27 | 29 | 36 | ||||||
| Minority Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 63 | 71 | 77 | 66 | 68 | 70 | 76 | 77 | 79 | 82 | 82 | 88 | ||||||
| Common Stock No Par Value | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | - | - | - | - | - | - | - | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
| Shares Outstanding | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCUMBERLAND PHARMACEUTICALS INC (CPIX) — SEC Financial Statements & Analysis
CUMBERLAND PHARMACEUTICALS INC (CPIX) is a pharmaceutical preparations company, incorporated in TN. CUMBERLAND PHARMACEUTICALS INC trades on Nasdaq as: CPIX. CUMBERLAND PHARMACEUTICALS INC (CPIX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, CUMBERLAND PHARMACEUTICALS INC carries a market cap of $75.28M, a P/E ratio of -6.89x, a P/B ratio of 4.40x, a P/S ratio of 1.89x, an enterprise value of $71.42M, and an EV/EBITDA multiple of -10.34x. On profitability, it posts a gross margin of 87.06%, an operating margin of -27.68%, a net margin of -27.37%, a Return on Equity (ROE) of -48.44%, a Return on Assets (ROA) of -16.70%, and a Return on Invested Capital (ROIC) of -82.48%. Per share, it reports EPS of $-0.73, diluted EPS of $-0.73, free cash flow per share of $0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -5.15% year-over-year, net income growth of 274.46% year-over-year, and EPS growth of 273.94% year-over-year. On the balance sheet, it maintains a current ratio of 0.96x, a quick ratio of 0.94x, working capital of $-1.55M, a debt-to-equity ratio of 2.68x, a debt ratio of 0.73, an interest coverage ratio of -26.41x, free cash flow of $468.94K (TTM), and net debt of $-3.86M. Figures sourced from SEC EDGAR.
- Market Cap
- $75.28M
- P/E TTM
- -6.89x
- EPS TTM
- $-0.73
- P/B TTM
- 4.40x
- ROE TTM
- -48.44%
- ROA TTM
- -16.70%
- Debt To Equity
- 2.68x
- Free Cash Flow TTM
- $468.94K
- Net Revenue TTM Growth 1Y
- -5.15%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CUMBERLAND PHARMACEUTICALS INC in?
CUMBERLAND PHARMACEUTICALS INC (CPIX) operates in the Pharmaceutical Preparations industry.
What exchange does CPIX trade on?
CUMBERLAND PHARMACEUTICALS INC (CPIX) trades on the Nasdaq.
Where is CUMBERLAND PHARMACEUTICALS INC incorporated?
CUMBERLAND PHARMACEUTICALS INC is incorporated in TN.
When was CUMBERLAND PHARMACEUTICALS INC (CPIX)'s most recent SEC filing?
CUMBERLAND PHARMACEUTICALS INC (CPIX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is CPIX's market cap?
CUMBERLAND PHARMACEUTICALS INC (CPIX) has a market capitalization of $75.28M as of 2026-06-30.
What is CPIX's EPS (earnings per share)?
CUMBERLAND PHARMACEUTICALS INC (CPIX)'s trailing twelve month EPS is $-0.73 as of 2026-06-30.
What is CPIX's ROE (return on equity)?
CUMBERLAND PHARMACEUTICALS INC (CPIX)'s trailing twelve month Return on Equity (ROE) is -48.44% as of 2026-06-30.
What is CPIX's ROA (return on assets)?
CUMBERLAND PHARMACEUTICALS INC (CPIX)'s trailing twelve month Return on Assets (ROA) is -16.70% as of 2026-06-30.
What is CPIX's ROIC (return on invested capital)?
CUMBERLAND PHARMACEUTICALS INC (CPIX)'s trailing twelve month Return on Invested Capital (ROIC) is -82.48% as of 2026-06-30.
What is CPIX's EV/EBITDA?
CUMBERLAND PHARMACEUTICALS INC (CPIX)'s trailing twelve month EV/EBITDA is -10.34x as of 2026-06-30.